BRAINSTORM CELL
BRAINSTORM CELL operates in Diversified Metals & Mining.
BRAINSTORM CELL (GHDN) - Total Assets
Latest total assets as of June 2024: €5.68 Million EUR
Based on the latest financial reports, BRAINSTORM CELL (GHDN) holds total assets worth €5.68 Million EUR as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
BRAINSTORM CELL - Total Assets Trend (2016–2022)
This chart illustrates how BRAINSTORM CELL’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
BRAINSTORM CELL - Asset Composition Analysis
Current Asset Composition (December 2022)
BRAINSTORM CELL's total assets of €5.68 Million consist of 36.8% current assets and 63.3% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 9.1% |
| Accounts Receivable | €0.00 | 0.0% |
| Inventory | €0.00 | 0.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €0.00 | 0.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2016–2022)
This chart illustrates how BRAINSTORM CELL's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BRAINSTORM CELL's current assets represent 36.8% of total assets in 2022, a decrease from 97.0% in 2016.
- Cash Position: Cash and equivalents constituted 9.1% of total assets in 2022, up from 5.1% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
BRAINSTORM CELL Competitors by Total Assets
Key competitors of BRAINSTORM CELL based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
XIWANG SPECIAL STEE (2XI.SG)
STU:2XI
|
Germany | €15.07 Billion |
|
LINDT & SPRUENGLI N - Dusseldorf Stock Exchang
DU:LSPN
|
Germany | €7.86 Billion |
|
PRICELINE.COM
BE:PCE1
|
Germany | €27.98 Billion |
|
PRICELINE GROUP (PCE1.SG)
STU:PCE1
|
Germany | €27.98 Billion |
|
MURPHY USA
BE:1MU
|
Germany | €4.40 Billion |
|
RESMED (RME.SG)
STU:RME
|
Germany | €7.22 Billion |
|
DIOS EXPLORATIONS
BE:BFM
|
Germany | €7.25 Million |
|
CHINA YUCHAI INTL (CYD.SG)
STU:CYD
|
Germany | €25.76 Billion |
BRAINSTORM CELL - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - BRAINSTORM CELL generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - BRAINSTORM CELL is currently not profitable relative to its asset base.
BRAINSTORM CELL - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.50 | 0.16 | 0.52 |
| Quick Ratio | 0.50 | 0.16 | 0.52 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-3.88 Million | € -6.48 Million | € -5.01 Million |
BRAINSTORM CELL - Advanced Valuation Insights
This section examines the relationship between BRAINSTORM CELL's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -71.1% |
| Total Assets | €8.45 Million |
| Market Capitalization | $30.34K USD |
Valuation Analysis
Below Book Valuation: The market values BRAINSTORM CELL's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: BRAINSTORM CELL's assets decreased by 71.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for BRAINSTORM CELL (2016–2022)
The table below shows the annual total assets of BRAINSTORM CELL from 2016 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | €8.45 Million | -71.13% |
| 2021-12-31 | €29.28 Million | -42.88% |
| 2020-12-31 | €51.26 Million | +684.50% |
| 2019-12-31 | €6.53 Million | -41.81% |
| 2018-12-31 | €11.23 Million | -1.71% |
| 2017-12-31 | €11.42 Million | +6.10% |
| 2016-12-31 | €10.77 Million | -- |